{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:46:26Z","timestamp":1791639986928,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004363","name":"Swisse Wellness PTY LTD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.atherosclerosis.2025.119177","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T07:43:32Z","timestamp":1742715812000},"page":"119177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The effects of a novel nutraceutical combination on low-density lipoprotein cholesterol and other markers of cardiometabolic health in adults with hypercholesterolaemia: A randomised double-blind placebo-controlled trial"],"prefix":"10.1016","volume":"403","author":[{"given":"Welma","family":"Stonehouse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Benassi-Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Louise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2025.119177_bib1","series-title":"Cardiovascular Diseases","year":"2017"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib2","series-title":"Australia's Health 2018: in Brief","year":"2018"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"Force Members","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib4","series-title":"Guidelines for the Management of Absolute Cardiovascular Disease Risk","year":"2012"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib5","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.2903\/j.efsa.2012.2693","article-title":"Scientific Opinion on the substantiation of a health claim related to 3 g\/day plant sterols\/stanols and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to Article 19 of Regulation (EC) No 1924\/2006","volume":"10","year":"2012","journal-title":"EFSA J."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijcard.2013.08.125","article-title":"Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia","volume":"170","author":"Gliozzi","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib7","first-page":"136","article-title":"Hypoglycemic and hypolipemic effects of a new lecithin formulation of bergamot polyphenolic fraction: a double blind, randomized, placebo- controlled study, endocrine, metabolic & immune disorders drug","volume":"19","author":"Mollace","year":"2019","journal-title":"Targets"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib8","first-page":"299","article-title":"Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: a 6 Months prospective study","volume":"6","author":"Toth","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112580","article-title":"Altilix(\u00ae) supplement containing chlorogenic acid and luteolin improved hepatic and cardiometabolic parameters in subjects with metabolic syndrome: a 6 Month randomized, double-blind, placebo-controlled study","volume":"11","author":"Castellino","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib10","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1080\/10408398.2017.1332572","article-title":"Lipid-lowering activity of artichoke extracts: a systematic review and meta-analysis","volume":"58","author":"Sahebkar","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib11","first-page":"2033","article-title":"Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage","volume":"9","year":"2011","journal-title":"EFSA J."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jff.2013.12.029","article-title":"Hypocholesterolaemic activity of 3-hydroxy-3-methyl-glutaryl flavanones enriched fraction from bergamot fruit (Citrus bergamia): \"In vivo\" studies","volume":"7","author":"Di Donna","year":"2014","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0022-3565(24)37701-8","article-title":"Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts","volume":"286","author":"Gebhardt","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ptr.960","article-title":"Inhibition of cholesterol biosynthesis in HepG2 cells by artichoke extracts is reinforced by glucosidase pretreatment","volume":"16","author":"Gebhardt","year":"2002","journal-title":"Phytother Res. : PT"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib15","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1021\/jf102576j","article-title":"On the inhibitor effects of bergamot juice flavonoids binding to the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) enzyme","volume":"58","author":"Leopoldini","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib16","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1021\/jf071772i","article-title":"Hypolipidemic effects of Citrus bergamia Risso et Poiteau juice in rats fed a hypercholesterolemic diet","volume":"55","author":"Miceli","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/ptr.3698","article-title":"Artichoke extract lowered plasma cholesterol and increased fecal bile acids in Golden Syrian hamsters","volume":"26","author":"Qiang","year":"2012","journal-title":"Phytother Res. : PT"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1078\/094471102321621278","article-title":"Choleretic activity and biliary elimination of lipids and bile acids induced by an artichoke leaf extract in rats","volume":"9","author":"Saenz Rodriguez","year":"2002","journal-title":"Phytomedicine : Int. Phytotherapy Phytopharmacol."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib19","series-title":"Biochemical, Physiological and Molecular Aspects of Human Nutrition","first-page":"1212","author":"Stipanuk","year":"2006"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib20","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/mnfr.201100722","article-title":"Effects of plant sterols and stanols on intestinal cholesterol metabolism: suggested mechanisms from past to present","volume":"56","author":"De Smet","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2008.06.026","article-title":"New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism","volume":"203","author":"Calpe-Berdiel","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3945\/ajcn.2009.28070","article-title":"Dose effects of dietary phytosterols on cholesterol metabolism: a controlled feeding study","volume":"91","author":"Racette","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib23","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2174\/138161211795428795","article-title":"Plant sterols and stanols in the treatment of dyslipidemia: new insights into targets and mechanisms related to cardiovascular risk","volume":"17","author":"Baumgartner","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000251","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"7","author":"Schulz","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib25","series-title":"Australian Cardiovascular Risk Charts","year":"2018"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib26","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jand.2012.04.016","article-title":"The Automated Self-Administered 24-hour dietary recall (ASA24): a resource for researchers, clinicians, and educators from the National Cancer Institute","volume":"112","author":"Subar","year":"2012","journal-title":"J. Acad. Nutr. Diet."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib27","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists\u2019","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib28","first-page":"1905","article-title":"ICH E9 expert working group, statistical principles for clinical trials: ICH harmonized tripartite guideline","volume":"18","year":"1999","journal-title":"Stat. Med."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/sim.1647","article-title":"Committee for Proprietary Medicinal Products (CPMP): points to consider on adjustment for baseline covariates","volume":"23","year":"2004","journal-title":"Stat. Med."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/sim.4431","article-title":"Improper analysis of trials randomised using stratified blocks or minimisation","volume":"31","author":"Kahan","year":"2012","journal-title":"Stat. Med."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib31","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jand.2013.07.006","article-title":"Cholesterol-lowering efficacy of plant sterols\/stanols provided in capsule and tablet formats: results of a systematic review and meta-analysis","volume":"113","author":"Amir Shaghaghi","year":"2013","journal-title":"J. Acad. Nutr. Diet."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib32","doi-asserted-by":"crossref","DOI":"10.3402\/fnr.v52i0.1811","article-title":"Plant sterols\/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials","volume":"52","author":"Abumweis","year":"2008","journal-title":"Food Nutr. Res."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3945\/jn.108.095125","article-title":"Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake","volume":"139","author":"Demonty","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/nu10091262","article-title":"LDL-cholesterol lowering of plant sterols and stanols-which factors influence their efficacy?","volume":"10","author":"Trautwein","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1211\/0022357056343","article-title":"Phytostanol tablets reduce human LDL-cholesterol","volume":"57","author":"McPherson","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092108","article-title":"A randomized, placebo-controlled, double-blind crossover study to assess a unique phytosterol ester formulation in lowering LDL cholesterol utilizing a novel virtual tracking Tool","volume":"11","author":"Reaver","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/nu16193370","article-title":"Plant sterol-enriched palm oil intervention to improve lipid profile and inflammation status in hyperlipidemic individuals","volume":"16","author":"Dewi","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib38","first-page":"5136","article-title":"NaA, Guidance for the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health","volume":"16","year":"2018","journal-title":"EFSA J."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib39","first-page":"295","article-title":"Diurnal variation of LDL and HDL cholesterol","volume":"12","author":"Miettinen","year":"1980","journal-title":"Ann. Clin. Res."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib40","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/bmj.327.7418.788","article-title":"Taking simvastatin in the morning compared with in the evening: randomised controlled trial","volume":"327","author":"Wallace","year":"2003","journal-title":"Bmj"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093128","article-title":"Nutraceutical combinations in hypercholesterolemia: evidence from randomized, placebo-controlled clinical trials","volume":"13","author":"Protic","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7326\/0003-4819-145-5-200609050-00006","article-title":"The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial","volume":"145","author":"Covas","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3945\/jn.109.112912","article-title":"Elevated circulating LDL phenol levels in men who consumed virgin rather than refined olive oil are associated with less oxidation of plasma LDL","volume":"140","author":"de la Torre-Carbot","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00394-004-0452-8","article-title":"Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation--a randomized controlled trial","volume":"43","author":"Marrugat","year":"2004","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib45","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/jn\/134.9.2314","article-title":"Olive oils high in phenolic compounds modulate oxidative\/antioxidative status in men","volume":"134","author":"Weinbrenner","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1139\/y2012-060","article-title":"Metabolic and genetic factors modulating subject specific LDL-C responses to plant sterol therapy","volume":"90","author":"Rideout","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib47","doi-asserted-by":"crossref","first-page":"724","DOI":"10.5740\/jaoacint.SGEJones","article-title":"Inter-individual variability in response to plant sterol and stanol consumption","volume":"98","author":"Jones","year":"2015","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2005.09.007","article-title":"Cholestanol: a serum marker to guide LDL cholesterol-lowering therapy","volume":"184","author":"Hoenig","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","article-title":"Gut microbiota functions: metabolism of nutrients and other food components","volume":"57","author":"Rowland","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9091881","article-title":"Cholesterol-to-Coprostanol conversion by the gut microbiota: what we know, suspect, and ignore","volume":"9","author":"Juste","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40168-020-00821-0","article-title":"Gut microbiota and cardiovascular disease: opportunities and challenges","volume":"8","author":"Kazemian","year":"2020","journal-title":"Microbiome"},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158074","article-title":"The role of gut microbiota on cholesterol metabolism in atherosclerosis","volume":"22","author":"Vourakis","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2025.119177_bib53","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fphar.2020.00278","article-title":"Unraveling host-gut microbiota dialogue and its impact on cholesterol levels","volume":"11","author":"Villette","year":"2020","journal-title":"Front. Pharmacol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:47:59Z","timestamp":1746064079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":53,"alternative-id":["S0021915025000759"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119177","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of a novel nutraceutical combination on low-density lipoprotein cholesterol and other markers of cardiometabolic health in adults with hypercholesterolaemia: A randomised double-blind placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119177"}}